{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T18:21:33Z","timestamp":1784571693319,"version":"3.55.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016724","name":"Postgraduate Institute of Medical Education and Research, Chandigarh","doi-asserted-by":"publisher","award":["Chandigarh-160,012"],"award-info":[{"award-number":["Chandigarh-160,012"]}],"id":[{"id":"10.13039\/100016724","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.pnpbp.2024.111126","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T12:32:45Z","timestamp":1724416365000},"page":"111126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Neuroprotective effect of PPAR gamma agonist in rat model of autism spectrum disorder: Role of Wnt\/\u03b2-catenin pathway"],"prefix":"10.1016","volume":"135","author":[{"given":"Arushi","family":"Sandhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajal","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipasha","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokesh","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lekha","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2024.111126_bb0005","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","article-title":"[13] catalase in vitro","volume":"105","author":"Aebi","year":"1984","journal-title":"Methods Enzymol. Elsevier"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0010","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.2147\/DDDT.S367229","article-title":"Protective effects of pioglitazone on cognitive impairment and the underlying mechanisms: a review of literature","author":"Alhowail","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0015","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nrm2717","article-title":"Proximal events in Wnt signal transduction","volume":"10","author":"Angers","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0020","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijdevneu.2004.11.001","article-title":"The teratology of autism","volume":"23","author":"Arndt","year":"2005","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109793","article-title":"Neuroprotective effect of PPAR alpha and gamma agonists in a mouse model of amyloidogenesis through modulation of the Wnt\/beta catenin pathway via targeting alpha-and beta-secretases","volume":"97","author":"Assaf","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0030","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1074\/jbc.M112.409250","article-title":"Inhibition of glycogen synthase kinase-3 ameliorates \u03b2-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies","volume":"288","author":"Avrahami","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116363","article-title":"Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid","volume":"10","author":"Baronio","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13229-017-0160-x","article-title":"Developmental disruption of amygdala transcriptome and socioemotional behavior in rats exposed to valproic acid prenatally","volume":"8","author":"Barrett","year":"2017","journal-title":"Mol. Autism"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/138161206780574579","article-title":"PPAR-\u03b3 agonists as regulators of microglial activation and brain inflammation","volume":"12","author":"Bernardo","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.21307\/ane-2017-025","article-title":"Immune dysfunction and neuroinflammation in autism spectrum disorder","volume":"76","author":"Bjorklund","year":"2016","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-4-3","article-title":"Effect of pioglitazone treatment on behavioral symptoms in autistic children","volume":"4","author":"Boris","year":"2007","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0060","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuropharm.2016.07.034","article-title":"Transcriptional dysregulation causes altered modulation of inhibition by haloperidol","volume":"111","author":"Brady","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1471-4159.2011.07189.x","article-title":"Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism","volume":"117","author":"Chauhan","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/0028-3886.253970","article-title":"Prevalence of autism spectrum disorder in Indian children: a systematic review and meta-analysis","volume":"67","author":"Chauhan","year":"2019","journal-title":"Neurol. India"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0075","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1161\/CIRCRESAHA.110.233775","article-title":"Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPAR\u03b3 and LXR\u03b1 pathways","volume":"108","author":"Chinetti-Gbaguidi","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/712758","article-title":"What we have learned about autism spectrum disorder from valproic acid","volume":"2013","author":"Chomiak","year":"2013","journal-title":"Pathol. Res. Int."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0085","doi-asserted-by":"crossref","first-page":"34266","DOI":"10.1074\/jbc.M006160200","article-title":"Glycogen synthase kinase-3\u03b2 activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal","volume":"275","author":"Crowder","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0090","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1038\/sj.onc.1204892","article-title":"Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1","volume":"20","author":"Eischen","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1113966","article-title":"Canagliflozin alleviates valproic acid-induced autism in rat pups: role of PTEN\/PDK\/PPAR-\u03b3 signaling pathways","volume":"14","author":"Elgamal","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0100","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1242\/dev.127.24.5285","article-title":"The WNT antagonist cSFRP2 modulates programmed cell death in the developing hindbrain","volume":"127","author":"Ellies","year":"2000","journal-title":"Development"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110185","article-title":"Validation of prenatal versus postnatal valproic acid rat models of autism: a behavioral and neurobiological study","volume":"108","author":"Elnahas","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0110","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.nbd.2009.09.003","article-title":"Wnt signaling in development and disease","volume":"38","author":"Freese","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0115","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/13543784.2017.1265504","article-title":"Pioglitazone for the treatment of Alzheimer\u2019s disease","volume":"26","author":"Galimberti","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-017-0809-3","article-title":"Valproic acid in women and girls of childbearing age","volume":"19","author":"Gotlib","year":"2017","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/jnc.15460","article-title":"Potential crosstalk between sonic hedgehog-WNT signaling and neurovascular molecules: implications for blood\u2013brain barrier integrity in autism spectrum disorder","volume":"159","author":"Gozal","year":"2021","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0130","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00125-009-1615-1","article-title":"Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesis","volume":"53","author":"Gustafson","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0135","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neubiorev.2016.03.013","article-title":"Understanding autism and other neurodevelopmental disorders through experimental translational neurobehavioral models","volume":"65","author":"Homberg","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0140","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/01616412.2020.1823107","article-title":"Propofol ameliorates neuropathic pain and neuroinflammation through PPAR \u03b3 up-regulation to block Wnt\/\u03b2-catenin pathway","volume":"43","author":"Jiang","year":"2021","journal-title":"Neurol. Res."},{"issue":"48","key":"10.1016\/j.pnpbp.2024.111126_bb0145","first-page":"e2473","article-title":"Assessment of social interaction behaviors","volume":"25","author":"Kaidanovich-Beilin","year":"2011","journal-title":"JoVE"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2040-2392-3-10","article-title":"A review of the evidence for the canonical Wnt pathway in autism spectrum disorders","volume":"3","author":"Kalkman","year":"2012","journal-title":"Mol. Autism"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0155","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2741\/2802","article-title":"Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists","volume":"13","author":"Kapadia","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10567-012-0119-6","article-title":"Parent and family impact of autism spectrum disorders: a review and proposed model for intervention evaluation","volume":"15","author":"Karst","year":"2012","journal-title":"Clin. Child. Fam. Psychol. Rev."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0165","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/35013000","article-title":"Roles of PPARs in health and disease","volume":"405","author":"Kersten","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0170","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejmech.2016.09.058","article-title":"Natural and synthetic bioactive inhibitors of glycogen synthase kinase","volume":"125","author":"Khan","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15287394.2021.1967821","article-title":"Metabolomics profiling of valproic acid-induced symptoms resembling autism spectrum disorders using 1H NMR spectral analysis in rat model","volume":"85","author":"Kim","year":"2022","journal-title":"J. Toxicol. Environ. Health A"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197060","article-title":"Pioglitazone abolishes autistic-like behaviors via the IL-6 pathway","volume":"13","author":"Kirsten","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0185","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.11103","article-title":"The autistic-like behaviors development during weaning and sexual maturation in VPA-induced autistic-like rats is accompanied by gut microbiota dysbiosis","volume":"9","author":"Kong","year":"2021","journal-title":"PeerJ"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0190","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0003-9861(78)90479-4","article-title":"Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase","volume":"186","author":"Kono","year":"1978","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11689-016-9176-3","article-title":"Wnt signaling networks in autism spectrum disorder and intellectual disability","volume":"8","author":"Kwan","year":"2016","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2016.00100","article-title":"Opposite interplay between PPAR gamma and canonical Wnt\/beta-catenin pathway in amyotrophic lateral sclerosis","volume":"7","author":"Lecarpentier","year":"2016","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104918","article-title":"Nuclear factor kappa B in autism spectrum disorder: a systematic review","volume":"159","author":"Liao","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0210","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0215","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173663","article-title":"Attenuation of neurobehavioural abnormalities by papaverine in prenatal valproic acid rat model of ASD","volume":"890","author":"Luhach","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0225","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.ss7011a1","article-title":"Prevalence and characteristics of autism spectrum disorder among children aged 8 years\u2014autism and developmental disabilities monitoring network, 11 Sites, United States, 2018","volume":"70","author":"Maenner","year":"2021","journal-title":"MMWR Surveill. Summ."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0230","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s12031-022-02033-7","article-title":"Critical evaluation of valproic acid-induced rodent models of autism: current and future perspectives","volume":"72","author":"Mehra","year":"2022","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0235","article-title":"The role of the prefrontal cortex in social interactions of animal models and the implications for autism spectrum disorder","volume":"14","author":"Mohapatra","year":"2023","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0240","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj20030426","article-title":"Peroxisome-proliferator-activated receptor \u03b3 suppresses Wnt\/\u03b2-catenin signalling during adipogenesis","volume":"376","author":"Moldes","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0245","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK epilepsy and pregnancy register","volume":"77","author":"Morrow","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0250","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11748-015-0576-1","article-title":"PPAR-\u03b3 agonist attenuates inflammation in aortic aneurysm patients","volume":"63","author":"Motoki","year":"2015","journal-title":"Gen. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0255","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s11481-012-9404-x","article-title":"Wnt signaling in vertebrate neural development and function","volume":"7","author":"Mulligan","year":"2012","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0260","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12017-018-8488-8","article-title":"Neuroimmunologic and neurotrophic interactions in autism spectrum disorders: relationship to neuroinflammation","volume":"20","author":"Ohja","year":"2018","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0265","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0270","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1073\/pnas.0901676106","article-title":"COUP-TFII acts downstream of Wnt\/\u03b2-catenin signal to silence PPAR\u03b3 gene expression and repress adipogenesis","volume":"106","author":"Okamura","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0275","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fncel.2013.00224","article-title":"Wnts in adult brain: from synaptic plasticity to cognitive deficiencies","volume":"7","author":"Oliva","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00316","article-title":"Genetic syndromes, maternal diseases and antenatal factors associated with autism spectrum disorders (ASD)","volume":"10","author":"Ornoy","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0285","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/s12276-023-01065-2","article-title":"Dysregulation of the Wnt\/\u03b2-catenin signaling pathway via Rnf146 upregulation in a VPA-induced mouse model of autism spectrum disorder","volume":"55","author":"Park","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0295","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1203\/PDR.0b013e318212b80f","article-title":"Modeling autistic features in animals","volume":"69","author":"Patterson","year":"2011","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0300","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0305","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","article-title":"Emerging roles of caspase-3 in apoptosis","volume":"6","author":"Porter","year":"1999","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0310","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.mcn.2016.06.004","article-title":"Valproic acid exposure sequentially activates Wnt and mTOR pathways in rats","volume":"75","author":"Qin","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0315","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7555\/JBR.34.20200057","article-title":"Valproic acid therapy decreases serum 25-hydroxyvitamin D level in female infants and toddlers with epilepsy\u2014a pilot longitudinal study","volume":"35","author":"Qiu","year":"2021","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0320","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000362205","article-title":"Prenatal exposure to the viral mimetic poly I: C alters fetal brain cytokine expression and postnatal behaviour","volume":"36","author":"Ratnayake","year":"2014","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0325","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neuroscience.2010.06.069","article-title":"Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid","volume":"170","author":"Roullet","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0330","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5214\/ans.0972.7531.260106","article-title":"Negative geotaxis: an early age behavioral hallmark to VPA rat model of autism","volume":"26","author":"Ruhela","year":"2019","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0335","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fncel.2019.00385","article-title":"Genetic causes and modifiers of autism spectrum disorder","volume":"13","author":"Rylaarsdam","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0340","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.brainresbull.2011.06.007","article-title":"Epigallocatechin gallate ameliorates behavioral and biochemical deficits in rat model of load-induced chronic fatigue syndrome","volume":"86","author":"Sachdeva","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0345","first-page":"2","article-title":"Characterization of four types of tail abnormalities in rats treated prenatally with valproic acid","volume":"5","author":"Saft","year":"2014","journal-title":"Eneurobiolog\u00eda"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0350","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3390\/ph14101025","article-title":"Repurposing peroxisome proliferator-activated receptor agonists in neurological and psychiatric disorders","volume":"14","author":"Sagheddu","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0355","doi-asserted-by":"crossref","first-page":"173721","DOI":"10.1016\/j.pbb.2024.173721","article-title":"Ameliorating effect of pioglitazone on prenatal valproic acid-induced behavioral and neurobiological abnormalities in autism spectrum disorder in rats","volume":"237","author":"Sandhu","year":"2024","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0360","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0370","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","article-title":"Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman\u2019s reagent","volume":"25","author":"Sedlak","year":"1968","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","article-title":"Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species","volume":"106","author":"Semple","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0380","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1089\/scd.2014.0230","article-title":"Small-molecule inhibitor of glycogen synthase kinase 3\u03b2 6-bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice","volume":"24","author":"Shen","year":"2015","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0385","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11662-7","article-title":"6-bromo-indirubin-3\u2032-oxime (6BIO), a glycogen synthase kinase-3\u03b2 inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts","volume":"7","author":"Sklirou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0390","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijdevneu.2011.03.008","article-title":"Morphological abnormalities of embryonic cranial nerves after in utero exposure to valproic acid: implications for the pathogenesis of autism with multiple developmental anomalies","volume":"29","author":"Tashiro","year":"2011","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0395","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s12264-018-0219-5","article-title":"Opposite interplay between the canonical WNT\/\u03b2-catenin pathway and PPAR gamma: a potential therapeutic target in gliomas","volume":"34","author":"Vall\u00e9e","year":"2018","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0400","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41380-018-0131-4","article-title":"PPAR\u03b3 agonists: potential treatment for autism spectrum disorder by inhibiting the canonical WNT\/\u03b2-catenin pathway","volume":"24","author":"Vall\u00e9e","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21775\/cimb.031.001","article-title":"Hypothesis of opposite interplay between the canonical WNT\/beta-catenin pathway and PPAR gamma in primary central nervous system lymphomas","volume":"31","author":"Vall\u00e9e","year":"2019","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0410","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00441-007-0432-4","article-title":"Immunohistological markers for staging neurogenesis in adult hippocampus","volume":"329","author":"von Bohlen Und Halbach","year":"2007","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0415","article-title":"Utilizing the modified T-maze to assess functional memory outcomes after cardiac arrest","volume":"131","author":"Wu","year":"2018","journal-title":"JoVE"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1125428","article-title":"Microglia and astrocytes underlie neuroinflammation and synaptic susceptibility in autism spectrum disorder","volume":"17","author":"Xiong","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0425","article-title":"Early behavioral abnormalities and perinatal alterations of PTEN\/AKT pathway in valproic acid autism model mice","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pnpbp.2024.111126_bb0430","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s11064-012-0724-2","article-title":"Downregulating the canonical Wnt\/\u03b2-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress","volume":"37","author":"Zhang","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0435","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ymthe.2016.10.017","article-title":"6BIO enhances oligonucleotide activity in cells: a potential combinatorial anti-androgen receptor therapy in prostate cancer cells","volume":"25","author":"Zhang","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.pnpbp.2024.111126_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154965","article-title":"Luteolin in the qi bi Anshen decoction improves propionic acid-induced autism-like behavior in rats by inhibiting LRP1\/MMP9","volume":"118","author":"Zhang","year":"2023","journal-title":"Phytomedicine"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624001945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624001945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T05:01:15Z","timestamp":1726290075000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624001945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":86,"alternative-id":["S0278584624001945"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111126","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effect of PPAR gamma agonist in rat model of autism spectrum disorder: Role of Wnt\/\u03b2-catenin pathway","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111126"}}